A total of 139 drugs, including cabozantinib and PD0325901, were predicted to be more effective in HPV (−) HNSCC cases characterized by high expression of mutated FAT1 (Fig. 1B). The gene discussed is FAT1; the disease is head and neck squamous cell carcinoma.